UF Health Cancer Center researchers Drs. Zhang, Zhou and Zheng Immunotherapy is a type of cancer treatment designed to boost the body’s natural defenses to fight the cancer. It uses substances either made by the body or in a laboratory to improve or restore immune system function, according to…
Health conditions, lifestyle choices and family history can all increase your risk of heart disease. But did you know that cancer and heart disease have been linked?
“Some protection is better than no protection,” said Dr. Merry J. Markham, acting chief of the Division of Hematology & Oncology at UF Health, to the Florida Political Review.
Dr. Joseph V. Simone We are saddened to share the news that Joseph V. Simone, M.D., former UF Health Cancer Center director and pioneering clinical investigator, passed away January 21, 2021, at the age of 85.An internationally recognized leader in cancer care, research and education, Simone’s research led…
Drs. Angel Sampson and Andria Doty recently teamed up with Dr. Jatinder Lamba in the department of pharmacotherapy and translational research in the UF College of Pharmacy, and Dr. Soheil Meshinchi at the Fred Hutchinson Cancer Research Center, University of Washington, in an effort to further understand the therapeutic relevance of various forms of the CD33 protein as it relates to the antibody-drug therapy. CD33 is expressed on malignant cancer cells in nearly all patients with acute myeloid leukemia (AML) and there has been a long-standing interest in the development of CD33-directed monoclonal antibodies for the treatment of AML.
On Jan. 8, the Florida Cancer Control and Research Advisory Council (CCRAB), North Central Florida Cancer Control Collaborative (NCFCCC), and UF Health Cancer Center hosted Cancer in the Time of Coronavirus: The COVID-19 Vaccine webinar on Zoom. In this webinar, speakers Christopher Cogle, M.D., and…
As the new COVID-19 vaccines are being put to use throughout the country, some people may have questions related to getting inoculated and healthy practices they should follow afterward.
Despite the lack of information on the safety of COVID-19 vaccines in people with cancer, many vaccinations are recommended for people with cancer, including the pneumococcal pneumonia vaccine and the flu vaccine.
The risks and benefits for immunocompromised patients receiving a SARS-CoV-2 vaccine should be weighed on a case-by-case basis, with consideration of the incidence of infection in the community.
Universities and health care entities throughout the state of Florida are now providing outreach and engagement to ethnic and racial minority communities disproportionately affected by the COVID-19 pandemic, thanks to a $1 million award from the National Institutes of Health (NIH).
